Re: "desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder: Design, Definitions, and Ongoing Challenges for Child and Adolescent Psychopharmacology Research" by Strawn JR and Croarkin PE (J Child Adolesc Psychopharmacol 2018;28:(5)363)

Karen L Weihs, Dalia B. Wajsbrot, Deborah Chiles, Sara Ramaker, Phil Chappell

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)245-246
Number of pages2
JournalJournal of child and adolescent psychopharmacology
Volume29
Issue number3
DOIs
StatePublished - Apr 1 2019

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this